These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 28469214)

  • 1. Response to Del Chiaro et al.
    Farrell JJ
    Am J Gastroenterol; 2017 May; 112(5):804-805. PubMed ID: 28469214
    [No Abstract]   [Full Text] [Related]  

  • 2. On pancreatic cancer screening by magnetic resonance imaging with the recent evidence by Del Chiaro and colleagues.
    Wáng YX; Gong JS; Loffroy R
    Chin J Cancer Res; 2015 Aug; 27(4):417-22. PubMed ID: 26361411
    [No Abstract]   [Full Text] [Related]  

  • 3. Functional variants in cell death pathway genes and risk of pancreatic cancer.
    Yang M; Sun T; Wang L; Yu D; Zhang X; Miao X; Liu J; Zhao D; Li H; Tan W; Lin D
    Clin Cancer Res; 2008 May; 14(10):3230-6. PubMed ID: 18483392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic neuroendocrine tumors: entering a new era.
    Oberstein PE; Remotti H; Saif MW; Libutti SK
    JOP; 2012 Mar; 13(2):169-73. PubMed ID: 22406593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers in pancreatic adenocarcinoma.
    Joza N; Saif MW
    JOP; 2014 Jul; 15(4):308-9. PubMed ID: 25076328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement by Callery et al.
    Choti MA; Dixon E; Tyler D
    Ann Surg Oncol; 2009 Jul; 16(7):1734-5. PubMed ID: 19390901
    [No Abstract]   [Full Text] [Related]  

  • 7. Correspondence re: Weinberg et al., Cholecystokinin and gastrin levels are not elevated in pancreatic carcinoma. Cancer Epidemiol. Biomark. Prev., 10: 721-722, 2001.
    Watson SA; Caplin M
    Cancer Epidemiol Biomarkers Prev; 2002 Feb; 11(2):219. PubMed ID: 11867513
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comment on the contribution by R. Bittner et al.: Effect of tumor size and lymph node status on prognosis of pancreatic cancer].
    Gall FP; Hermanek P
    Chirurg; 1990 May; 61(5):411-3. PubMed ID: 2364777
    [No Abstract]   [Full Text] [Related]  

  • 9. SMAD4/DPC4 and pancreatic cancer survival. Commentary re: M. Tascilar et al., The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. Clin. Cancer Res., 7: 4115-4121, 2001.
    Liu F
    Clin Cancer Res; 2001 Dec; 7(12):3853-6. PubMed ID: 11751474
    [No Abstract]   [Full Text] [Related]  

  • 10. Motivational beliefs, cognitive engagement, and achievement in language and mathematics in elementary school children.
    Metallidou P; Vlachou A
    Int J Psychol; 2007 Feb; 42(1):2-15. PubMed ID: 24274775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical treatment of resectable and borderline resectable pancreatic cancer: expert consensus statement by Evans et al.
    Adams RB; Allen PJ
    Ann Surg Oncol; 2009 Jul; 16(7):1745-50. PubMed ID: 19396494
    [No Abstract]   [Full Text] [Related]  

  • 12. Correspondence re: Seki et al., Diagnosis of pancreatic adenocarcinoma by detection of human telomerase reverse transcriptase messenger RNA in pancreatic juice with sample qualification. Clin. Cancer Res., 7: 1976-1981, 2001.
    Hindle KS; Kirkpatrick K; Mokbel K
    Clin Cancer Res; 2002 Feb; 8(2):628-9. PubMed ID: 11839686
    [No Abstract]   [Full Text] [Related]  

  • 13. Correspondence re: D. S. Swaffar et al., Inhibition of the growth of human pancreatic cancer cells by the arginine antimetabolite L-canavanine. Cancer Res., 54: 6045-6048, 1994.
    Cann SA; van Netten JP; Ross AS
    Cancer Res; 1995 Oct; 55(19):4486-7. PubMed ID: 7671264
    [No Abstract]   [Full Text] [Related]  

  • 14. Research gaps in pancreatic cancer research and comparative effectiveness research methodologies.
    In H; Posner MC
    Cancer Treat Res; 2015; 164():165-94. PubMed ID: 25677024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New tools and novel approaches in treating locally advanced pancreatic adenocarcinoma.
    Ahmed WB; Ng J; Wazer DE; Saif MW
    JOP; 2012 Jul; 13(4):354-7. PubMed ID: 22797388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on novel therapies for pancreatic neuroendocrine tumors.
    Oberstein PE; Saif MW
    JOP; 2012 Jul; 13(4):372-5. PubMed ID: 22797392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regarding the article by Martignoni et al.
    Gudjonsson B
    Am J Surg; 2006 Jan; 191(1):142. PubMed ID: 16399126
    [No Abstract]   [Full Text] [Related]  

  • 18. Update on prognostic and predictive biomarkers for pancreatic neuroendocrine tumors.
    Oberstein PE; Saif MW
    JOP; 2012 Jul; 13(4):368-71. PubMed ID: 22797391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyst Fluid Analysis in Pancreatic Intraductal Papillary Mucinous Neoplasms.
    Allen PJ; Iacobuzio-Donahue CA; Klimstra DS
    Clin Cancer Res; 2016 Oct; 22(20):4966-4967. PubMed ID: 27573170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comment on P. Fricke et al.: Multiple metachronous metastases of renal cell carcinoma in the pancreas].
    Keller E
    Chirurg; 2000 Dec; 71(12):1527. PubMed ID: 11195078
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.